Alnylam Pharmaceuticals, Inc.

FIL Ltd ALNY
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
92,038
Value ($000)
27,706
Weight
0.0%
2022 Q3 - 2026 Q2 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).